Field Medical Advisor Hematology
Johnson & Johnson is currently seeking a Field Medical Advisor Hematology to join our Medical Affairs team located in Norway (Oslo).
At Johnson & Johnson,?we believe health is everything. Our strength in healthcare innovation empowers us to build a?world where complex diseases are prevented, treated, and cured,?where treatments are smarter and less invasive, and?solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
Hematologic malignancies are one of Janssen’s key focus areas with a world leading portfolio in treatment for multiple myeloma and chronic lymphocytic leukemia. Our mission is to transform cancer from a deadly disease into preventable, chronic or curable diseases through the development of therapeutic alternatives that extend and improve the quality of life of the patients. www.janssen.com/oncology
Field Medical Advisor (FMA) Hematology
In this role you will be working with our innovative medications in their current and future indications as well as with our pipeline products. As an FMA you will be our scientific and medical specialist and work closely with the Norwegian leading physicians in the relevant therapeutic areas. In addition to scientific exchange with leading physicians you also have a critical role in attracting clinicals studies to Norway and leading the medical education and evidence generation planning and execution in Norway.
You will be part of the hematology team where your focus will be on our B-cell malignancies portfolio and pipeline which cover many different treatment targets and treatment approaches including CAR-T’s, bi- and trispecific antibodies and oral medications. The future focus of this role will depend on your preferences and organizational needs.
The primary focus of the FMA role is on external activities and partnerships with key opinion leaders and other stakeholders. As an FMA you will also be a key member of the Norwegian cross-functional teams in the Janssen Norway country organization. You are also part of a strong network within the Therapeutic Areas across Janssen in the Nordics and Europe. The position is based in Norway (preferably Oslo area) and reports directly to the Country Medical Lead. The position will require travel, mostly within Norway, up to 1-3 days/week in addition to occasional longer congress travel.
Key Responsibilities:
Responsibilities of a Field Medical Advisor
- Develop and maintain a network with leading specialist physicians with a particular focus on understanding their needs, key value drivers, and practical treatment patterns, as well as championing the medical value of own products.
- Communicate medical scientific data to leading specialists and broader external health care related audience, both proactively and reactively.
- Gain valuable insights into treatment patterns and scientific activities in the therapeutic area through scientific interactions and provide strategic input to the medical affairs plan and business decision-making.
- Develop, coordinate and participate in medical education activities, e.g. identify, support, and educate speakers as well as build medical education programs with scientific third parties.
- Provide medical input to cross-functional communication and action plans, support material generation and approvals seeking to improve use of multi-channel communication with our customers.
- Lead the medical training of the internal cross-functional team.
- Build a network internally with relevant global and European stakeholders.
- Lead local evidence generation programs in collaboration with the market access team. Facilitate for getting clinical studies within the field to Norway and assist with execution of those studies.
- Support the market access team in medical and scientific input to HTA submissions as applicable.
- Work with internal and external stakeholders to attract clinical studies to Norway,facilitate smooth feasibility processes as well as initiation and running of studies taking place in Norway
